<DOC>
	<DOCNO>NCT01795326</DOCNO>
	<brief_summary>A physician survey document receipt metabolic educational material assess behavior physician follow message communicate educational material</brief_summary>
	<brief_title>Physician Survey Monitoring Patients Treated With Quetiapine</brief_title>
	<detailed_description>Assessment physician behavior regard metabolic monitoring patient treat SEROQUEL® ( quetiapine fumarate ) Tablets SEROQUEL® ( quetiapine fumarate ) Extended Release Tablets select country EU</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Physicians target receive metabolic educational material either currently prescribe potential prescribe SEROQUEL® SEROQUEL® XR . Physicians participate survey involve SEROQUEL® / SEROQUEL® XR past six month eligible participate survey .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Effectiveness risk minimization</keyword>
	<keyword>Metabolic monitoring</keyword>
	<keyword>Seroquel®</keyword>
	<keyword>Seroquel® XR/quetiapine fumarate</keyword>
</DOC>